Europe Diabetes Pen- Market

Diabetes Pen- Comprehensive Study by Type (Reusable Pens, Disposable Pens), Application (Type 1 Diabetes, Type 2 Diabetes), End Users (Hospitals, Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sale, Others) Players and Region - Europe Market Outlook to 2030

Diabetes Pen- Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 6.6%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
A diabetes pen is a medical device designed to assist individuals with diabetes in administering insulin. Insulin pens provide a convenient and precise method for injecting insulin, a hormone that helps regulate blood sugar levels in people with diabetes. These pens are portable, easy to use, and often preferred by individuals who need to self-administer insulin. There are two main types of diabetes pens including disposable and reusable pens. The European diabetes pen market exhibits several drivers, restraints, and opportunities. A major driver is the increasing prevalence of diabetes in the region, necessitating effective insulin delivery methods. Technological advancements in diabetes pen technology, such as the integration of smart features, contribute to market growth. However, high initial costs and limited reimbursement policies act as restraints, impacting the widespread adoption of diabetes pens. Despite these challenges, opportunities arise from the untapped potential in emerging markets within Europe and the potential for collaborations between healthcare stakeholders to enhance awareness and accessibility. Continuous research and development efforts to improve product efficacy and cost-effectiveness further present avenues for market expansion in the European diabetes pen segment.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledAstraZeneca (United Kingdom), Teruma Medical (Japan ), Greiner Bio-One International GmbH (Austria), Roche (Switzerland), Becton, Dickinson and Company (United States), IQVIA Inc. (United States), Novo Nordisk (Denmark), Sanofi (France) and Eli Lilly (United States)


According to AMA, the market for Diabetes Pen- is expected to register a CAGR of 6.6% during the forecast period to 2030. This growth is primarily driven by Increasing incidence of diabetes globally and Continuous innovation in pen technology.

Globally, a noticeable market trend is evident Integration of smart technologies, such as Bluetooth connectivity and dose tracking Major Players, such as AstraZeneca (United Kingdom), Teruma Medical (Japan ), Greiner Bio-One International GmbH (Austria), Roche (Switzerland), Becton, Dickinson and Company (United States), IQVIA Inc. (United States), Novo Nordisk (Denmark), Sanofi (France) and Eli Lilly (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. The diabetes pen market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance.

In March 2022, Novo Nordisk launched smart insulin pens available in the UK giving the NHS for Diabetics access to devices that can monitor and record dosing information for the same time.

Influencing Trend:
Integration of smart technologies, such as Bluetooth connectivity and dose tracking

Market Growth Drivers:
Increasing incidence of diabetes globally and Continuous innovation in pen technology

Challenges:
Competition from other insulin delivery methods, such as insulin pumps and Stringent regulatory requirements for approval of new diabetes pen

Restraints:
High cost of smart insulin pens and Inadequate reimbursement policies for diabetes pens

Opportunities:
Untapped markets in developing countries and Ongoing research and development to create innovative and cost-effective diabetes pen

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Diabetes Pen- Market
- Analysis about New Entrants in Diabetes Pen- Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Diabetes Pen- Study Sheds Light on
— The Diabetes Pen- Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Diabetes Pen- industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Diabetes Pen- industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Reusable Pens
  • Disposable Pens
By Application
  • Type 1 Diabetes
  • Type 2 Diabetes
By End Users
  • Hospitals
  • Clinics
  • Others

By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sale
  • Others

By Regions
  • Germany
  • France
  • Italy
  • United Kingdom
  • Netherlands
  • Rest of Europe
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing incidence of diabetes globally
      • 3.2.2. Continuous innovation in pen technology
    • 3.3. Market Challenges
      • 3.3.1. Competition from other insulin delivery methods, such as insulin pumps
      • 3.3.2. Stringent regulatory requirements for approval of new diabetes pen
    • 3.4. Market Trends
      • 3.4.1. Integration of smart technologies, such as Bluetooth connectivity and dose tracking
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Europe Diabetes Pen-, by Type, Application, End Users, Distribution Channel and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Europe Diabetes Pen- (Value)
      • 5.2.1. Europe Diabetes Pen- by: Type (Value)
        • 5.2.1.1. Reusable Pens
        • 5.2.1.2. Disposable Pens
      • 5.2.2. Europe Diabetes Pen- by: Application (Value)
        • 5.2.2.1. Type 1 Diabetes
        • 5.2.2.2. Type 2 Diabetes
      • 5.2.3. Europe Diabetes Pen- by: End Users (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Others
      • 5.2.4. Europe Diabetes Pen- by: Distribution Channel (Value)
        • 5.2.4.1. Hospital Pharmacy
        • 5.2.4.2. Retail Pharmacy
        • 5.2.4.3. Online Sale
        • 5.2.4.4. Others
      • 5.2.5. Europe Diabetes Pen- Region
        • 5.2.5.1. Germany
        • 5.2.5.2. France
        • 5.2.5.3. Italy
        • 5.2.5.4. United Kingdom
        • 5.2.5.5. Netherlands
        • 5.2.5.6. Rest of Europe
    • 5.3. Europe Diabetes Pen- (Volume)
      • 5.3.1. Europe Diabetes Pen- by: Type (Volume)
        • 5.3.1.1. Reusable Pens
        • 5.3.1.2. Disposable Pens
      • 5.3.2. Europe Diabetes Pen- by: Application (Volume)
        • 5.3.2.1. Type 1 Diabetes
        • 5.3.2.2. Type 2 Diabetes
      • 5.3.3. Europe Diabetes Pen- by: End Users (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Clinics
        • 5.3.3.3. Others
      • 5.3.4. Europe Diabetes Pen- by: Distribution Channel (Volume)
        • 5.3.4.1. Hospital Pharmacy
        • 5.3.4.2. Retail Pharmacy
        • 5.3.4.3. Online Sale
        • 5.3.4.4. Others
      • 5.3.5. Europe Diabetes Pen- Region
        • 5.3.5.1. Germany
        • 5.3.5.2. France
        • 5.3.5.3. Italy
        • 5.3.5.4. United Kingdom
        • 5.3.5.5. Netherlands
        • 5.3.5.6. Rest of Europe
    • 5.4. Europe Diabetes Pen- (Price)
      • 5.4.1. Europe Diabetes Pen- by: Type (Price)
  • 6. Diabetes Pen-: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. AstraZeneca (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Teruma Medical (Japan )
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Greiner Bio-One International GmbH (Austria)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Roche (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Becton, Dickinson and Company (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. IQVIA Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Novo Nordisk (Denmark)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Sanofi (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Eli Lilly (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Europe Diabetes Pen- Sale, by Type, Application, End Users, Distribution Channel and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Europe Diabetes Pen- (Value)
      • 7.2.1. Europe Diabetes Pen- by: Type (Value)
        • 7.2.1.1. Reusable Pens
        • 7.2.1.2. Disposable Pens
      • 7.2.2. Europe Diabetes Pen- by: Application (Value)
        • 7.2.2.1. Type 1 Diabetes
        • 7.2.2.2. Type 2 Diabetes
      • 7.2.3. Europe Diabetes Pen- by: End Users (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Others
      • 7.2.4. Europe Diabetes Pen- by: Distribution Channel (Value)
        • 7.2.4.1. Hospital Pharmacy
        • 7.2.4.2. Retail Pharmacy
        • 7.2.4.3. Online Sale
        • 7.2.4.4. Others
      • 7.2.5. Europe Diabetes Pen- Region
        • 7.2.5.1. Germany
        • 7.2.5.2. France
        • 7.2.5.3. Italy
        • 7.2.5.4. United Kingdom
        • 7.2.5.5. Netherlands
        • 7.2.5.6. Rest of Europe
    • 7.3. Europe Diabetes Pen- (Volume)
      • 7.3.1. Europe Diabetes Pen- by: Type (Volume)
        • 7.3.1.1. Reusable Pens
        • 7.3.1.2. Disposable Pens
      • 7.3.2. Europe Diabetes Pen- by: Application (Volume)
        • 7.3.2.1. Type 1 Diabetes
        • 7.3.2.2. Type 2 Diabetes
      • 7.3.3. Europe Diabetes Pen- by: End Users (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Clinics
        • 7.3.3.3. Others
      • 7.3.4. Europe Diabetes Pen- by: Distribution Channel (Volume)
        • 7.3.4.1. Hospital Pharmacy
        • 7.3.4.2. Retail Pharmacy
        • 7.3.4.3. Online Sale
        • 7.3.4.4. Others
      • 7.3.5. Europe Diabetes Pen- Region
        • 7.3.5.1. Germany
        • 7.3.5.2. France
        • 7.3.5.3. Italy
        • 7.3.5.4. United Kingdom
        • 7.3.5.5. Netherlands
        • 7.3.5.6. Rest of Europe
    • 7.4. Europe Diabetes Pen- (Price)
      • 7.4.1. Europe Diabetes Pen- by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Diabetes Pen-: by Type(USD Million)
  • Table 2. Diabetes Pen- Reusable Pens , by Region USD Million (2018-2023)
  • Table 3. Diabetes Pen- Disposable Pens , by Region USD Million (2018-2023)
  • Table 4. Diabetes Pen-: by Application(USD Million)
  • Table 5. Diabetes Pen- Type 1 Diabetes , by Region USD Million (2018-2023)
  • Table 6. Diabetes Pen- Type 2 Diabetes , by Region USD Million (2018-2023)
  • Table 7. Diabetes Pen-: by End Users(USD Million)
  • Table 8. Diabetes Pen- Hospitals , by Region USD Million (2018-2023)
  • Table 9. Diabetes Pen- Clinics , by Region USD Million (2018-2023)
  • Table 10. Diabetes Pen- Others , by Region USD Million (2018-2023)
  • Table 11. Diabetes Pen-: by Distribution Channel(USD Million)
  • Table 12. Diabetes Pen- Hospital Pharmacy , by Region USD Million (2018-2023)
  • Table 13. Diabetes Pen- Retail Pharmacy , by Region USD Million (2018-2023)
  • Table 14. Diabetes Pen- Online Sale , by Region USD Million (2018-2023)
  • Table 15. Diabetes Pen- Others , by Region USD Million (2018-2023)
  • Table 16. Germany Diabetes Pen-, by Type USD Million (2018-2023)
  • Table 17. Germany Diabetes Pen-, by Application USD Million (2018-2023)
  • Table 18. Germany Diabetes Pen-, by End Users USD Million (2018-2023)
  • Table 19. Germany Diabetes Pen-, by Distribution Channel USD Million (2018-2023)
  • Table 20. France Diabetes Pen-, by Type USD Million (2018-2023)
  • Table 21. France Diabetes Pen-, by Application USD Million (2018-2023)
  • Table 22. France Diabetes Pen-, by End Users USD Million (2018-2023)
  • Table 23. France Diabetes Pen-, by Distribution Channel USD Million (2018-2023)
  • Table 24. Italy Diabetes Pen-, by Type USD Million (2018-2023)
  • Table 25. Italy Diabetes Pen-, by Application USD Million (2018-2023)
  • Table 26. Italy Diabetes Pen-, by End Users USD Million (2018-2023)
  • Table 27. Italy Diabetes Pen-, by Distribution Channel USD Million (2018-2023)
  • Table 28. United Kingdom Diabetes Pen-, by Type USD Million (2018-2023)
  • Table 29. United Kingdom Diabetes Pen-, by Application USD Million (2018-2023)
  • Table 30. United Kingdom Diabetes Pen-, by End Users USD Million (2018-2023)
  • Table 31. United Kingdom Diabetes Pen-, by Distribution Channel USD Million (2018-2023)
  • Table 32. Netherlands Diabetes Pen-, by Type USD Million (2018-2023)
  • Table 33. Netherlands Diabetes Pen-, by Application USD Million (2018-2023)
  • Table 34. Netherlands Diabetes Pen-, by End Users USD Million (2018-2023)
  • Table 35. Netherlands Diabetes Pen-, by Distribution Channel USD Million (2018-2023)
  • Table 36. Rest of Europe Diabetes Pen-, by Type USD Million (2018-2023)
  • Table 37. Rest of Europe Diabetes Pen-, by Application USD Million (2018-2023)
  • Table 38. Rest of Europe Diabetes Pen-, by End Users USD Million (2018-2023)
  • Table 39. Rest of Europe Diabetes Pen-, by Distribution Channel USD Million (2018-2023)
  • Table 40. Diabetes Pen- Sales: by Type(K Units)
  • Table 41. Diabetes Pen- Sales Reusable Pens , by Region K Units (2018-2023)
  • Table 42. Diabetes Pen- Sales Disposable Pens , by Region K Units (2018-2023)
  • Table 43. Diabetes Pen- Sales: by Application(K Units)
  • Table 44. Diabetes Pen- Sales Type 1 Diabetes , by Region K Units (2018-2023)
  • Table 45. Diabetes Pen- Sales Type 2 Diabetes , by Region K Units (2018-2023)
  • Table 46. Diabetes Pen- Sales: by End Users(K Units)
  • Table 47. Diabetes Pen- Sales Hospitals , by Region K Units (2018-2023)
  • Table 48. Diabetes Pen- Sales Clinics , by Region K Units (2018-2023)
  • Table 49. Diabetes Pen- Sales Others , by Region K Units (2018-2023)
  • Table 50. Diabetes Pen- Sales: by Distribution Channel(K Units)
  • Table 51. Diabetes Pen- Sales Hospital Pharmacy , by Region K Units (2018-2023)
  • Table 52. Diabetes Pen- Sales Retail Pharmacy , by Region K Units (2018-2023)
  • Table 53. Diabetes Pen- Sales Online Sale , by Region K Units (2018-2023)
  • Table 54. Diabetes Pen- Sales Others , by Region K Units (2018-2023)
  • Table 55. Germany Diabetes Pen- Sales, by Type K Units (2018-2023)
  • Table 56. Germany Diabetes Pen- Sales, by Application K Units (2018-2023)
  • Table 57. Germany Diabetes Pen- Sales, by End Users K Units (2018-2023)
  • Table 58. Germany Diabetes Pen- Sales, by Distribution Channel K Units (2018-2023)
  • Table 59. France Diabetes Pen- Sales, by Type K Units (2018-2023)
  • Table 60. France Diabetes Pen- Sales, by Application K Units (2018-2023)
  • Table 61. France Diabetes Pen- Sales, by End Users K Units (2018-2023)
  • Table 62. France Diabetes Pen- Sales, by Distribution Channel K Units (2018-2023)
  • Table 63. Italy Diabetes Pen- Sales, by Type K Units (2018-2023)
  • Table 64. Italy Diabetes Pen- Sales, by Application K Units (2018-2023)
  • Table 65. Italy Diabetes Pen- Sales, by End Users K Units (2018-2023)
  • Table 66. Italy Diabetes Pen- Sales, by Distribution Channel K Units (2018-2023)
  • Table 67. United Kingdom Diabetes Pen- Sales, by Type K Units (2018-2023)
  • Table 68. United Kingdom Diabetes Pen- Sales, by Application K Units (2018-2023)
  • Table 69. United Kingdom Diabetes Pen- Sales, by End Users K Units (2018-2023)
  • Table 70. United Kingdom Diabetes Pen- Sales, by Distribution Channel K Units (2018-2023)
  • Table 71. Netherlands Diabetes Pen- Sales, by Type K Units (2018-2023)
  • Table 72. Netherlands Diabetes Pen- Sales, by Application K Units (2018-2023)
  • Table 73. Netherlands Diabetes Pen- Sales, by End Users K Units (2018-2023)
  • Table 74. Netherlands Diabetes Pen- Sales, by Distribution Channel K Units (2018-2023)
  • Table 75. Rest of Europe Diabetes Pen- Sales, by Type K Units (2018-2023)
  • Table 76. Rest of Europe Diabetes Pen- Sales, by Application K Units (2018-2023)
  • Table 77. Rest of Europe Diabetes Pen- Sales, by End Users K Units (2018-2023)
  • Table 78. Rest of Europe Diabetes Pen- Sales, by Distribution Channel K Units (2018-2023)
  • Table 79. Diabetes Pen-: by Type(USD/Units)
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Company Basic Information, Sales Area and Its Competitors
  • Table 82. Company Basic Information, Sales Area and Its Competitors
  • Table 83. Company Basic Information, Sales Area and Its Competitors
  • Table 84. Company Basic Information, Sales Area and Its Competitors
  • Table 85. Company Basic Information, Sales Area and Its Competitors
  • Table 86. Company Basic Information, Sales Area and Its Competitors
  • Table 87. Company Basic Information, Sales Area and Its Competitors
  • Table 88. Company Basic Information, Sales Area and Its Competitors
  • Table 89. Diabetes Pen-: by Type(USD Million)
  • Table 90. Diabetes Pen- Reusable Pens , by Region USD Million (2025-2030)
  • Table 91. Diabetes Pen- Disposable Pens , by Region USD Million (2025-2030)
  • Table 92. Diabetes Pen-: by Application(USD Million)
  • Table 93. Diabetes Pen- Type 1 Diabetes , by Region USD Million (2025-2030)
  • Table 94. Diabetes Pen- Type 2 Diabetes , by Region USD Million (2025-2030)
  • Table 95. Diabetes Pen-: by End Users(USD Million)
  • Table 96. Diabetes Pen- Hospitals , by Region USD Million (2025-2030)
  • Table 97. Diabetes Pen- Clinics , by Region USD Million (2025-2030)
  • Table 98. Diabetes Pen- Others , by Region USD Million (2025-2030)
  • Table 99. Diabetes Pen-: by Distribution Channel(USD Million)
  • Table 100. Diabetes Pen- Hospital Pharmacy , by Region USD Million (2025-2030)
  • Table 101. Diabetes Pen- Retail Pharmacy , by Region USD Million (2025-2030)
  • Table 102. Diabetes Pen- Online Sale , by Region USD Million (2025-2030)
  • Table 103. Diabetes Pen- Others , by Region USD Million (2025-2030)
  • Table 104. Germany Diabetes Pen-, by Type USD Million (2025-2030)
  • Table 105. Germany Diabetes Pen-, by Application USD Million (2025-2030)
  • Table 106. Germany Diabetes Pen-, by End Users USD Million (2025-2030)
  • Table 107. Germany Diabetes Pen-, by Distribution Channel USD Million (2025-2030)
  • Table 108. France Diabetes Pen-, by Type USD Million (2025-2030)
  • Table 109. France Diabetes Pen-, by Application USD Million (2025-2030)
  • Table 110. France Diabetes Pen-, by End Users USD Million (2025-2030)
  • Table 111. France Diabetes Pen-, by Distribution Channel USD Million (2025-2030)
  • Table 112. Italy Diabetes Pen-, by Type USD Million (2025-2030)
  • Table 113. Italy Diabetes Pen-, by Application USD Million (2025-2030)
  • Table 114. Italy Diabetes Pen-, by End Users USD Million (2025-2030)
  • Table 115. Italy Diabetes Pen-, by Distribution Channel USD Million (2025-2030)
  • Table 116. United Kingdom Diabetes Pen-, by Type USD Million (2025-2030)
  • Table 117. United Kingdom Diabetes Pen-, by Application USD Million (2025-2030)
  • Table 118. United Kingdom Diabetes Pen-, by End Users USD Million (2025-2030)
  • Table 119. United Kingdom Diabetes Pen-, by Distribution Channel USD Million (2025-2030)
  • Table 120. Netherlands Diabetes Pen-, by Type USD Million (2025-2030)
  • Table 121. Netherlands Diabetes Pen-, by Application USD Million (2025-2030)
  • Table 122. Netherlands Diabetes Pen-, by End Users USD Million (2025-2030)
  • Table 123. Netherlands Diabetes Pen-, by Distribution Channel USD Million (2025-2030)
  • Table 124. Rest of Europe Diabetes Pen-, by Type USD Million (2025-2030)
  • Table 125. Rest of Europe Diabetes Pen-, by Application USD Million (2025-2030)
  • Table 126. Rest of Europe Diabetes Pen-, by End Users USD Million (2025-2030)
  • Table 127. Rest of Europe Diabetes Pen-, by Distribution Channel USD Million (2025-2030)
  • Table 128. Diabetes Pen- Sales: by Type(K Units)
  • Table 129. Diabetes Pen- Sales Reusable Pens , by Region K Units (2025-2030)
  • Table 130. Diabetes Pen- Sales Disposable Pens , by Region K Units (2025-2030)
  • Table 131. Diabetes Pen- Sales: by Application(K Units)
  • Table 132. Diabetes Pen- Sales Type 1 Diabetes , by Region K Units (2025-2030)
  • Table 133. Diabetes Pen- Sales Type 2 Diabetes , by Region K Units (2025-2030)
  • Table 134. Diabetes Pen- Sales: by End Users(K Units)
  • Table 135. Diabetes Pen- Sales Hospitals , by Region K Units (2025-2030)
  • Table 136. Diabetes Pen- Sales Clinics , by Region K Units (2025-2030)
  • Table 137. Diabetes Pen- Sales Others , by Region K Units (2025-2030)
  • Table 138. Diabetes Pen- Sales: by Distribution Channel(K Units)
  • Table 139. Diabetes Pen- Sales Hospital Pharmacy , by Region K Units (2025-2030)
  • Table 140. Diabetes Pen- Sales Retail Pharmacy , by Region K Units (2025-2030)
  • Table 141. Diabetes Pen- Sales Online Sale , by Region K Units (2025-2030)
  • Table 142. Diabetes Pen- Sales Others , by Region K Units (2025-2030)
  • Table 143. Germany Diabetes Pen- Sales, by Type K Units (2025-2030)
  • Table 144. Germany Diabetes Pen- Sales, by Application K Units (2025-2030)
  • Table 145. Germany Diabetes Pen- Sales, by End Users K Units (2025-2030)
  • Table 146. Germany Diabetes Pen- Sales, by Distribution Channel K Units (2025-2030)
  • Table 147. France Diabetes Pen- Sales, by Type K Units (2025-2030)
  • Table 148. France Diabetes Pen- Sales, by Application K Units (2025-2030)
  • Table 149. France Diabetes Pen- Sales, by End Users K Units (2025-2030)
  • Table 150. France Diabetes Pen- Sales, by Distribution Channel K Units (2025-2030)
  • Table 151. Italy Diabetes Pen- Sales, by Type K Units (2025-2030)
  • Table 152. Italy Diabetes Pen- Sales, by Application K Units (2025-2030)
  • Table 153. Italy Diabetes Pen- Sales, by End Users K Units (2025-2030)
  • Table 154. Italy Diabetes Pen- Sales, by Distribution Channel K Units (2025-2030)
  • Table 155. United Kingdom Diabetes Pen- Sales, by Type K Units (2025-2030)
  • Table 156. United Kingdom Diabetes Pen- Sales, by Application K Units (2025-2030)
  • Table 157. United Kingdom Diabetes Pen- Sales, by End Users K Units (2025-2030)
  • Table 158. United Kingdom Diabetes Pen- Sales, by Distribution Channel K Units (2025-2030)
  • Table 159. Netherlands Diabetes Pen- Sales, by Type K Units (2025-2030)
  • Table 160. Netherlands Diabetes Pen- Sales, by Application K Units (2025-2030)
  • Table 161. Netherlands Diabetes Pen- Sales, by End Users K Units (2025-2030)
  • Table 162. Netherlands Diabetes Pen- Sales, by Distribution Channel K Units (2025-2030)
  • Table 163. Rest of Europe Diabetes Pen- Sales, by Type K Units (2025-2030)
  • Table 164. Rest of Europe Diabetes Pen- Sales, by Application K Units (2025-2030)
  • Table 165. Rest of Europe Diabetes Pen- Sales, by End Users K Units (2025-2030)
  • Table 166. Rest of Europe Diabetes Pen- Sales, by Distribution Channel K Units (2025-2030)
  • Table 167. Diabetes Pen-: by Type(USD/Units)
  • Table 168. Research Programs/Design for This Report
  • Table 169. Key Data Information from Secondary Sources
  • Table 170. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Europe Diabetes Pen-: by Type USD Million (2018-2023)
  • Figure 5. Europe Diabetes Pen-: by Application USD Million (2018-2023)
  • Figure 6. Europe Diabetes Pen-: by End Users USD Million (2018-2023)
  • Figure 7. Europe Diabetes Pen-: by Distribution Channel USD Million (2018-2023)
  • Figure 8. Europe Diabetes Pen-: by Type K Units (2018-2023)
  • Figure 9. Europe Diabetes Pen-: by Application K Units (2018-2023)
  • Figure 10. Europe Diabetes Pen-: by End Users K Units (2018-2023)
  • Figure 11. Europe Diabetes Pen-: by Distribution Channel K Units (2018-2023)
  • Figure 12. Europe Diabetes Pen-: by Type USD/Units (2018-2023)
  • Figure 13. Europe Diabetes Pen- share by Players 2023 (%)
  • Figure 14. Europe Diabetes Pen- share by Players (Top 3) 2023(%)
  • Figure 15. Europe Diabetes Pen- share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. AstraZeneca (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 18. AstraZeneca (United Kingdom) Revenue: by Geography 2023
  • Figure 19. Teruma Medical (Japan ) Revenue, Net Income and Gross profit
  • Figure 20. Teruma Medical (Japan ) Revenue: by Geography 2023
  • Figure 21. Greiner Bio-One International GmbH (Austria) Revenue, Net Income and Gross profit
  • Figure 22. Greiner Bio-One International GmbH (Austria) Revenue: by Geography 2023
  • Figure 23. Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 24. Roche (Switzerland) Revenue: by Geography 2023
  • Figure 25. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 26. Becton, Dickinson and Company (United States) Revenue: by Geography 2023
  • Figure 27. IQVIA Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. IQVIA Inc. (United States) Revenue: by Geography 2023
  • Figure 29. Novo Nordisk (Denmark) Revenue, Net Income and Gross profit
  • Figure 30. Novo Nordisk (Denmark) Revenue: by Geography 2023
  • Figure 31. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 32. Sanofi (France) Revenue: by Geography 2023
  • Figure 33. Eli Lilly (United States) Revenue, Net Income and Gross profit
  • Figure 34. Eli Lilly (United States) Revenue: by Geography 2023
  • Figure 35. Europe Diabetes Pen-: by Type USD Million (2025-2030)
  • Figure 36. Europe Diabetes Pen-: by Application USD Million (2025-2030)
  • Figure 37. Europe Diabetes Pen-: by End Users USD Million (2025-2030)
  • Figure 38. Europe Diabetes Pen-: by Distribution Channel USD Million (2025-2030)
  • Figure 39. Europe Diabetes Pen-: by Type K Units (2025-2030)
  • Figure 40. Europe Diabetes Pen-: by Application K Units (2025-2030)
  • Figure 41. Europe Diabetes Pen-: by End Users K Units (2025-2030)
  • Figure 42. Europe Diabetes Pen-: by Distribution Channel K Units (2025-2030)
  • Figure 43. Europe Diabetes Pen-: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • AstraZeneca (United Kingdom)
  • Teruma Medical (Japan )
  • Greiner Bio-One International GmbH (Austria)
  • Roche (Switzerland)
  • Becton, Dickinson and Company (United States)
  • IQVIA Inc. (United States)
  • Novo Nordisk (Denmark)
  • Sanofi (France)
  • Eli Lilly (United States)
Additional players considered in the study are as follows:
Owen Mumford (United Kingdom) , Artsana Group (Italy) , Others
Select User Access Type

Key Highlights of Report


Feb 2024 242 Pages 75 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Europe Diabetes Pen- Market Quantitative research analysis
Europe Diabetes Pen- Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Europe Diabetes Pen- market are AstraZeneca (United Kingdom), Teruma Medical (Japan ), Greiner Bio-One International GmbH (Austria), Roche (Switzerland), Becton, Dickinson and Company (United States), IQVIA Inc. (United States), Novo Nordisk (Denmark), Sanofi (France) and Eli Lilly (United States), to name a few.
is dominating the Diabetes Pen- Market.
"Competition from other insulin delivery methods, such as insulin pumps " is seen as one of the major challenges by many Industry Players of Diabetes Pen- Market
The Diabetes Pen- market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Diabetes Pen- market is expected to see a steady growth rate during projected year 2023 to 2030.

Know More About Europe Diabetes Pen- Market Report?

Have a Query? Click Here

Other Related Reports

Advanced Ophthalmology Technologies- Comprehensive Study by Type (Diagnostic (Optical Coherence Tomography Scanners, Ophthalmic Ultrasound Imaging Systems, Wavefront Aberrometers, Optical Biometry Sy...
$ 3800
Chitin, Chitosan and Derivatives Comprehensive Study by Type (Chitin, Chitosan, Glucosamine, Others), Application (Healthcare & Pharmaceuticals, Water Treatment, Agriculture, Food & Beverages, Others...
$ 3800
OTC Vitamins and Minerals Dietary Supplement- Comprehensive Study by Type (Multivitamins, Vitamin Supplements, Mineral Supplements, Others), Application (Pain Relief, Sexual Wellness, Energy and Weig...
$ 3800
Whey Protein- Comprehensive Study by Type (Isolates, Concentrates, Hydrolysates), Application (Sports Nutrition, Dietary Supplements, Infant Formula, Food & Beverages, Pharmaceutical, Animal Feed, Ot...
$ 3800
Zirconia Dental Material- Comprehensive Study by Type (Zirconia dental disc, Zirconia dental block, Others), Application (Dental crowns, Dental bridges, Dentures, Others), End Users (Hospitals, Denta...
$ 3800
Contact and Intraocular Lenses Comprehensive Study by Type (Contact Lenses (Soft Contact Lenses, Rigid Gas Permeable (RGP) Contact Lenses, Extended Wear Contact Lenses, Disposable Contact Lenses, Oth...
$ 3800